Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

about

The Role of TAL1 in Hematopoiesis and Leukemogenesis.

P2860

Q54113323-B7E783C4-CD69-40D7-B4DC-1ADF8A5D1C85

P2860

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

Item

http://www.wikidata.org/entity/Q41343608

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Synergistic suppression of t(8 ...... nin and MAPK1/ERK2 inhibitors.

@en

type

Item

label

Synergistic suppression of t(8 ...... nin and MAPK1/ERK2 inhibitors.

@en

prefLabel

Synergistic suppression of t(8 ...... nin and MAPK1/ERK2 inhibitors.

@en

P1476

Synergistic suppression of t(8 ...... nin and MAPK1/ERK2 inhibitors.

@en

P2093

Alexey Morozov

http://www.w3.org/2001/XMLSchema#string

Anton Buzdin

http://www.w3.org/2001/XMLSchema#string

Carol Stocking

http://www.w3.org/2001/XMLSchema#string

Nadezhda Poymenova

http://www.w3.org/2001/XMLSchema#string

Natalia Orlova

http://www.w3.org/2001/XMLSchema#string

Olga Kovalchuk

http://www.w3.org/2001/XMLSchema#string

Pavel Spirin

http://www.w3.org/2001/XMLSchema#string

Sergey E Dmitriev

http://www.w3.org/2001/XMLSchema#string

Vladimir Prassolov

http://www.w3.org/2001/XMLSchema#string

P2860

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein

Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling

Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data.

Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

Unwinding the loop of Bcl-2 phosphorylation.

Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.

P304

56991-57002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18503

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timofei D. Lebedev

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28915648

http://www.w3.org/2001/XMLSchema#string

P932

5593619

http://www.w3.org/2001/XMLSchema#string

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

about

P2860

P2860

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932